PUBLISHER: The Business Research Company | PRODUCT CODE: 2035984
PUBLISHER: The Business Research Company | PRODUCT CODE: 2035984
Large language model (LLM)-powered genomic report drafting involves using advanced AI models trained on extensive biomedical and genomic data to generate detailed interpretations of genetic information. It automates the translation of complex genomic findings into clear, structured reports, emphasizing significant variants and their potential clinical implications. This approach enhances consistency, efficiency, and comprehensiveness in presenting genomic analyses.
The essential components of large language model (LLM) powered genomic report drafting include software and services. Software refers to AI-driven platforms that assist in generating genomic reports for clinical, research, and pharmacogenomic applications. Report types include diagnostic confirmation reports, carrier screening reports, predictive and pre-symptomatic test reports, pharmacogenomic reports, and research-use-only reports, deployed through cloud-based, on-premises, and hybrid solutions. Key applications include oncology, rare diseases, pharmacogenomics, reproductive health, inherited disorders, and infectious diseases, while end users include hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other organizations.
Tariffs on imported high-performance computing hardware, genomic sequencing instruments, and cloud infrastructure components have influenced the LLM-powered genomic report drafting market by increasing operational and infrastructure costs. Healthcare and life sciences segments relying on advanced servers and sequencing platforms are most affected, particularly in North America and Europe dependent on Asia-Pacific supply chains. Higher equipment costs may slow adoption among smaller laboratories; however, tariffs also promote domestic biotechnology manufacturing, local AI infrastructure development, and greater investment in regional genomic data ecosystems, strengthening long-term technological independence.
The large language model (LLM)-powered genomic report drafting market research report is one of a series of new reports from The Business Research Company that provides large language model (LLM)-powered genomic report drafting market statistics, including large language model (LLM)-powered genomic report drafting industry global market size, regional shares, competitors with a large language model (LLM)-powered genomic report drafting market share, detailed large language model (LLM)-powered genomic report drafting market segments, market trends and opportunities, and any further data you may need to thrive in the large language model (LLM)-powered genomic report drafting industry. This large language model (LLM)-powered genomic report drafting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The large language model (LLM)-powered genomic report drafting market size has grown exponentially in recent years. It will grow from $1.04 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to growth in next generation sequencing adoption, increasing demand for precision medicine, rising volume of genomic data, shortage of skilled genomic analysts, expansion of clinical genomics programs.
The large language model (LLM)-powered genomic report drafting market size is expected to see exponential growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to increasing integration of ai in clinical workflows, rising demand for personalized treatment strategies, growing investment in digital health infrastructure, expansion of cloud based genomic platforms, increasing regulatory emphasis on standardized reporting. Major trends in the forecast period include increasing automation of genomic variant interpretation, growing adoption of standardized genomic reporting templates, rising integration with clinical decision support systems, expansion of multimodal genomic data summarization, increasing focus on explainable ai in genomic reporting.
The rising focus on personalized medicine is projected to propel the growth of the large language model (LLM)-powered genomic report drafting market in the years ahead. Precision medicine is a medical approach that customizes the prevention, diagnosis, and treatment of diseases for individual patients based on their unique genetic makeup, environment, and lifestyle. The emphasis on personalized medicine is increasing due to the growing availability of genetic tests, which allow clinicians to analyze individual genetic profiles and design treatments tailored to each patient's specific biology. Large language model (LLM)-powered genomic report drafting advances personalized medicine by transforming complex genetic and sequencing data into clear, structured reports that highlight key variants, streamline interpretation, and enable personalized treatment strategies for patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized therapies for patients with rare diseases, representing a substantial increase from the six approvals in 2022. Hence, the rising focus on personalized medicine is driving the growth of the large language model (LLM)-powered genomic report drafting market.
Key companies operating in the large language model (LLM)-powered genomic report drafting market are focusing on leveraging innovative technologies such as artificial intelligence (AI)-assisted evidence synthesis to accelerate genomic data interpretation and generate accurate, actionable reports. Artificial intelligence (AI)-assisted evidence synthesis uses AI algorithms to automatically gather, analyze, and summarize genomic research and clinical data, helping accelerate genomic interpretation and generate accurate, actionable reports. For example, in October 2025, Breakthrough Genomics Inc., a US-based biotechnology company, launched its largest interpreted literature database at the American Society of Human Genetics (ASHG) 2025 Annual Meeting, which introduced enhanced artificial intelligence (AI)-assisted evidence synthesis capabilities within its Virtual Geneticist platform. The database combines millions of curated variant-paper associations with advanced natural language processing and large language model algorithms to automatically gather, analyze, and summarize genomic research and clinical data, generating structured clinical reports and prioritizing actionable insights. It integrates real-time literature updates, semantic analysis, and customizable report outputs, drastically reducing the time and manual effort required for genomic interpretation compared to traditional review methods. The platform supports applications in rare disease diagnosis, precision medicine, and research workflows, delivering rapid, reliable, and comprehensive genomic insights to clinicians and researchers.
In May 2025, GeneDx Inc., a US-based healthcare technology company, acquired Fabric Genomics, Inc. for an undisclosed amount. Through this acquisition, GeneDx Inc. aims to expand its genomic analysis capabilities and combine decentralized testing with centralized intelligence to accelerate precision medicine initiatives. Fabric Genomics Inc. is a US-based healthcare technology company specializing in AI-driven genomic interpretation software to support clinical decision-making in genetic testing.
Major companies operating in the large language model (llm) powered genomic report drafting market are Illumina Inc, QIAGEN NV, Tempus AI Inc, Color Health Inc, Helix Opco LLC, Owkin Inc, SOPHiA GENETICS SA, Genomenon Inc, DNAnexus Inc, Lifebit Ltd, Deep Genomics Incorporated, PierianDx Inc, Genixai, Data4Cure Inc, Nostos Genomics GmbH, 3billion Inc, Breakthrough Genomics, NTHRYS OPC PRIVATE LIMITED, Saphetor SA, Zifo Technologies Inc.
North America was the largest region in the large language model (LLM)-Powered genomic report drafting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the llm-powered genomic report drafting market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the large language model (LLM)-powered genomic report drafting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The large language model (LLM) powered genomic report drafting market consists of revenues earned by entities by providing services such as report generation for genetic testing results, integration of multi-omics data, clinical significance assessment of genetic variants, and generation of actionable insights for research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Large Language Model (LLM)-Powered Genomic Report Drafting Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses large language model (llm)-powered genomic report drafting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for large language model (llm)-powered genomic report drafting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The large language model (llm)-powered genomic report drafting market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.